150
Participants
Start Date
January 17, 2023
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Hyperpolarized Xenon-129 MRI of the lungs
Participants will be imaged using MRI using hyperpolarized xenon-129 gas as a contrast gas
Computed Tomography (CT)
Participants will undergo a CT scan of the thoracic cavity
Pulmonary Function Tests (PFT)
Participants will have their lung function evaluated using PFT
Cardiopulmonary exercise testing (CPET)
Participants will perform cardiopulmonary exercise testing as a measure of exercise capacity
Sputum analysis
Participants will provide a sputum sample that will be analysed for eosinophils
Blood analysis
Participants will have their blood drawn and analysed for eosinophil count.
Questionnaires
Participants will complete questionnaires to assess activity related dyspnea, respiratory symptoms and health status impairment and respiratory related quality of life.
RECRUITING
Robarts Research Institute; The University of Western Ontario; London Health Sciences Centre, London
Collaborators (1)
London Health Sciences Centre
OTHER
Western University, Canada
OTHER